3 Articles
3 Articles
Tufts chemists design a next generation of weight loss drugs
Tufts researchers led by Krishna Kumar, Robinson Professor of Chemistry, have designed a new, next-generation compound with hopes that it could be more effective with fewer side effects than Ozempic and Wegovy.While weight loss drugs currently on the market and in development target one, two, or even three hormone receptors related to glucose metabolism and the desire to eat, the Tufts team has identified a fourth target that could potentially f…
Tufts Chemists Design a Next Generation Weight Loss Drug
Tufts researchers have designed a new, next-generation compound with hopes that it could be more effective with fewer side effects than the currently popular GLP-1 drugs. The new drug targets four hormone receptors simultaneously, for a combined effect that modulates hunger, pace of digestion, blood glucose, energy and fat metabolism
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium